Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation)
COVID-19 is a disease that, in addition to respiratory failure, leads to thrombosis and bleeding due to coagulation disorders. Extracorporeal membrane oxygenation (ECMO), required in cases of a deterioration of gas exchange function of the lungs, contributes to changes in blood coagulation indicator...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
2022-01-01
|
| Series: | Неотложная медицинская помощь |
| Subjects: | |
| Online Access: | https://www.jnmp.ru/jour/article/view/1261 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839579980982386688 |
|---|---|
| author | S. V. Zhuravel V. V. Vladimirov P. V. Gavrilov I. V. Ivanov S. S. Petrikov K. A. Popugayev A. M. Talyzin |
| author_facet | S. V. Zhuravel V. V. Vladimirov P. V. Gavrilov I. V. Ivanov S. S. Petrikov K. A. Popugayev A. M. Talyzin |
| author_sort | S. V. Zhuravel |
| collection | DOAJ |
| description | COVID-19 is a disease that, in addition to respiratory failure, leads to thrombosis and bleeding due to coagulation disorders. Extracorporeal membrane oxygenation (ECMO), required in cases of a deterioration of gas exchange function of the lungs, contributes to changes in blood coagulation indicators, which leads to an increased risk of hemorrhagic complications and thrombosis. In the article, a clinical case of a severe course of COVID-19 is reported, which required ECMO. During the treatment, antithrombin-III was used, which allowed avoiding life-threatening complications and successfully completing the procedure. |
| format | Article |
| id | doaj-art-0bd197eb2a534d5ca48e9e2d5e7b242d |
| institution | Matheson Library |
| issn | 2223-9022 2541-8017 |
| language | Russian |
| publishDate | 2022-01-01 |
| publisher | Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department |
| record_format | Article |
| series | Неотложная медицинская помощь |
| spelling | doaj-art-0bd197eb2a534d5ca48e9e2d5e7b242d2025-08-04T10:30:23ZrusSklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare DepartmentНеотложная медицинская помощь2223-90222541-80172022-01-0110464264810.23934/2223-9022-2021-10-4-642-648724Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation)S. V. Zhuravel0V. V. Vladimirov1P. V. Gavrilov2I. V. Ivanov3S. S. Petrikov4K. A. Popugayev5A. M. Talyzin6N.V. Sklifosovsky Research Institute for Emergency MedicineN.V. Sklifosovsky Research Institute for Emergency MedicineN.V. Sklifosovsky Research Institute for Emergency MedicineN.V. Sklifosovsky Research Institute for Emergency MedicineN.V. Sklifosovsky Research Institute for Emergency MedicineN.V. Sklifosovsky Research Institute for Emergency MedicineN.V. Sklifosovsky Research Institute for Emergency MedicineCOVID-19 is a disease that, in addition to respiratory failure, leads to thrombosis and bleeding due to coagulation disorders. Extracorporeal membrane oxygenation (ECMO), required in cases of a deterioration of gas exchange function of the lungs, contributes to changes in blood coagulation indicators, which leads to an increased risk of hemorrhagic complications and thrombosis. In the article, a clinical case of a severe course of COVID-19 is reported, which required ECMO. During the treatment, antithrombin-III was used, which allowed avoiding life-threatening complications and successfully completing the procedure.https://www.jnmp.ru/jour/article/view/1261covid-19sars-cov-2ecmothrombosisbleedingantithrombinheparinanticoagulant therapy |
| spellingShingle | S. V. Zhuravel V. V. Vladimirov P. V. Gavrilov I. V. Ivanov S. S. Petrikov K. A. Popugayev A. M. Talyzin Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation) Неотложная медицинская помощь covid-19 sars-cov-2 ecmo thrombosis bleeding antithrombin heparin anticoagulant therapy |
| title | Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation) |
| title_full | Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation) |
| title_fullStr | Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation) |
| title_full_unstemmed | Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation) |
| title_short | Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation) |
| title_sort | antithrombin iii for new coronavirus infection covid 19 under conditions of extracorporeal membrane oxygenation clinical observation |
| topic | covid-19 sars-cov-2 ecmo thrombosis bleeding antithrombin heparin anticoagulant therapy |
| url | https://www.jnmp.ru/jour/article/view/1261 |
| work_keys_str_mv | AT svzhuravel antithrombiniiifornewcoronavirusinfectioncovid19underconditionsofextracorporealmembraneoxygenationclinicalobservation AT vvvladimirov antithrombiniiifornewcoronavirusinfectioncovid19underconditionsofextracorporealmembraneoxygenationclinicalobservation AT pvgavrilov antithrombiniiifornewcoronavirusinfectioncovid19underconditionsofextracorporealmembraneoxygenationclinicalobservation AT ivivanov antithrombiniiifornewcoronavirusinfectioncovid19underconditionsofextracorporealmembraneoxygenationclinicalobservation AT sspetrikov antithrombiniiifornewcoronavirusinfectioncovid19underconditionsofextracorporealmembraneoxygenationclinicalobservation AT kapopugayev antithrombiniiifornewcoronavirusinfectioncovid19underconditionsofextracorporealmembraneoxygenationclinicalobservation AT amtalyzin antithrombiniiifornewcoronavirusinfectioncovid19underconditionsofextracorporealmembraneoxygenationclinicalobservation |